Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.
about
Brivaracetam add-on therapy for epilepsyEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewProfile of brivaracetam and its potential in the treatment of epilepsySynaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and BeyondBrivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base[Brivaracetam for add-on treatment in focal epilepsy].New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.Emerging drugs for partial-onset epilepsy: a review of brivaracetamEfficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.New developments in the management of partial-onset epilepsy: role of brivaracetam.Pharmacotherapy of epilepsy: newly approved and developmental agents.Brivaracetam for the treatment of epilepsy.Recent and future antiepileptic drugs and their impact on cognition: what can we expect?Emerging drugs for focal epilepsy.Brivaracetam for the treatment of epilepsy in adults.The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.Evaluation of brivaracetam: a new drug to treat epilepsy.Brivaracetam for the treatment of epilepsy.Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Brivaracetam: First Global Approval.Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies.Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis.Brivaracetam, a Novel Antiepileptic Drug: Is it Effective and Safe? Results from One Phase III Randomized Trial.Brivaracetam disposition in mild to severe hepatic impairment.Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures.Effect of brivaracetam on CYP3A activity, measured by oral midazolam.Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
P2860
Q24188269-674A30D6-066F-4814-A8C9-0EC5E9868F5AQ26743786-0B864C6D-5427-4E4D-A646-65B2636980CDQ26776317-5867119F-9009-4801-AB4E-4ABA75A784E0Q28068507-2E3F5A2A-2FDE-40D3-BADB-C6E64EE0038FQ28076065-79216384-64C9-49D1-9D00-2F064BD6EC55Q30390285-6D36BAEB-B034-43B5-BB36-7A13C17A3B9EQ33949491-ECA9DA4B-B48B-4544-988C-B2A2839E1BB5Q35761335-EE5327FE-0AA6-4374-AD2D-81D3CA5739DDQ36891212-B4974755-0AA5-4700-82E3-CE21D75AF6CDQ37113376-269CEFAB-9EEA-4884-9710-F03DD0B1EB4EQ37693757-EC6A3C03-E34B-4D24-BCA7-E15FF23B6A65Q37831297-E4C65400-FFC0-4F00-BB7F-16CB0C04EA8CQ37891095-85C67777-E3C4-4BA5-89FF-7E6FD820056BQ38014887-96B30496-2DA0-4E39-B654-E7F9B920BD2EQ38062011-8DE5206C-7FAC-44CD-B713-AF9B3C073A65Q38195636-80E2FC23-0D6A-4F0A-9DE8-CA15FBC06BAFQ38614499-3E9FF159-A18F-4260-A86E-384E36067380Q38621010-C4B0612D-30B3-4E7C-A556-760C63FF5790Q38626838-AFEE9E4D-3E00-447B-BCC6-6D6C8C384CAFQ38652806-219278F0-F90D-4093-AF8B-8FF2530D4352Q38694479-1DA20672-4DBB-4272-8113-2481D62A5677Q38739649-CD032187-BDE2-4739-8E1A-FBF077C68FD6Q38743281-4A195FB3-A70C-4189-94E4-522C9633ECE5Q38752407-CD40CB39-45E1-43E3-A0E4-ED0B3C086720Q38844513-3EFC3C8A-8C19-4D34-9D95-278B20079C05Q38915714-622B7AA8-B704-42FD-BD8E-FCC7CE228D2CQ38922348-3CDC9C33-F5C5-4B68-ADC3-10AB60AF079FQ38985697-45E68B64-8169-4D8E-BE5C-A6B6ED127AE4Q39707630-0B20AA2D-A1DE-4B9B-B296-23F34D68E95EQ39794501-CAEA5994-D361-4486-AB64-504FAC633C56Q39899497-5DA66840-429F-4ED1-B50F-4B3BE80E8ECAQ41877287-AEEF4D35-54B2-430D-B3CD-78D8145388FDQ44231616-5725108F-C081-4027-B2BE-26BFA12CD3C5Q44773924-90F73C51-DA67-4766-88B3-20BAA0756FA7Q47326787-95E5EBE7-F3F5-4B9B-A7FC-82C656AF7509Q47774665-46539518-8E07-4CB8-8CA8-0FD094279C05Q47836472-71FC94EA-45F9-4A80-AADC-681DD961E443Q47853821-D62FEC01-D366-4D67-8269-BD3D7377A410Q47926989-B9B5D33B-33B9-4A15-B851-20A2BFB075D7Q48130509-BAB74C5A-8B5C-47C1-8DD3-FFEA6B685D30
P2860
Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@en
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@nl
type
label
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@en
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@nl
prefLabel
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@en
Adjunctive brivaracetam for re ...... randomized, controlled trial.
@nl
P2093
P1433
P1476
Adjunctive brivaracetam for re ...... a randomized, controlled trial
@en
P2093
C Costantini
J A French
N01193 Study Group
P304
P356
10.1212/WNL.0B013E3181EC7F7F
P407
P577
2010-06-30T00:00:00Z